Indigenously developed Zydus Cadila Coronavirus vaccine ZyCoV-D, has received approval for 'Emergency Use Authorisation' from the Drug Controller General of India (DCGI).
It will be administered to people 12 years and above, the Department of Biotechnology said on Friday.
"Zydus Cadila has received approval for Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D today i.E. 20/08/2021, the world's first and India's indigenously developed DNA-based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above," it said.
This is the world's first DNA-based COVID vaccine, and the three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance, it said.
The vaccine has been developed in partnership with the DBT under Mission COVID Suraksha, the department said.